1.615
4.44%
-0.075
Schlusskurs vom Vortag:
$1.69
Offen:
$1.68
24-Stunden-Volumen:
116.75K
Relative Volume:
0.18
Marktkapitalisierung:
$213.20M
Einnahmen:
$108.81M
Nettoeinkommen (Verlust:
$-186.70M
KGV:
-1.9181
EPS:
-0.842
Netto-Cashflow:
$-16.83M
1W Leistung:
+0.31%
1M Leistung:
+0.94%
6M Leistung:
+2.87%
1J Leistung:
+13.73%
Organigram Holdings Inc Stock (OGI) Company Profile
Vergleichen Sie OGI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
OGI
Organigram Holdings Inc
|
1.615 | 213.20M | 108.81M | -186.70M | -16.83M | -0.842 |
ZTS
Zoetis Inc
|
161.59 | 73.76B | 9.15B | 2.43B | 2.31B | 5.32 |
HLN
Haleon Plc Adr
|
9.415 | 42.77B | 14.26B | 1.55B | 0 | 0.3383 |
TAK
Takeda Pharmaceutical Co Adr
|
13.20 | 42.32B | 30.27B | 1.93B | 3.45B | 0.6044 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.41 | 24.47B | 16.77B | -959.00M | 1.37B | -0.85 |
VTRS
Viatris Inc
|
11.79 | 14.32B | 15.05B | -883.30M | 1.89B | -0.74 |
Organigram Holdings Inc Stock (OGI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-17 | Fortgesetzt | Canaccord Genuity | Speculative Buy |
2024-04-15 | Hochstufung | Alliance Global Partners | Neutral → Buy |
2023-01-13 | Hochstufung | Stifel | Hold → Buy |
2022-01-12 | Hochstufung | Canaccord Genuity | Hold → Speculative Buy |
2021-05-11 | Hochstufung | CIBC | Sector Underperform → Neutral |
2021-04-14 | Herabstufung | CIBC | Neutral → Sector Underperform |
2021-04-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
2021-03-10 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
2021-01-13 | Herabstufung | Alliance Global Partners | Buy → Neutral |
2021-01-13 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
2020-07-07 | Eingeleitet | Alliance Global Partners | Buy |
2020-01-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2020-01-13 | Eingeleitet | BofA/Merrill | Underperform |
2020-01-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2019-11-12 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
2019-11-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
2019-10-11 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Organigram Holdings Inc Aktie (OGI) Neueste Nachrichten
Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts? - Yahoo Finance
10 Best Pot Stocks To Invest In According to Analysts - Insider Monkey
Canada’s Organigram shops for U.S. pot businesses with backing from British American Tobacco - MSN
Alliance Global Partners Predicts Organigram Q1 Earnings - MarketBeat
Alliance Global Partners Comments on Organigram Q1 Earnings - MarketBeat
Atb Cap Markets Predicts Organigram Q1 Earnings - MarketBeat
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade) - Seeking Alpha
Organigram Reports Fourth Quarter and Fiscal 2024 Results - Business Wire
OrganiGram Holdings Inc. (NASDAQ:OGI) Q4 2024 Earnings Call Transcript - Insider Monkey
Atb Cap Markets Estimates Organigram Q4 Earnings - MarketBeat
Atb Cap Markets Forecasts Organigram Q3 Earnings - MarketBeat
Small caps to watch: Shares in Canadian fashion retailer slide after disappointing quarter - The Globe and Mail
FY2025 EPS Estimates for Organigram Cut by Atb Cap Markets - MarketBeat
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Organigram eyes global cannabis growth after Motif deal - Green Market Report
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion - GuruFocus.com
OrganiGram: Fiscal Q4 Earnings Snapshot - CT Insider
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
The small-cap rally has its skeptics: Morning Brief [Video] - AOL
Organigram Holdings: Fiscal 2024 Financial Highlights - TipRanks
Organigram (OGI) Q4 2024 Earnings Call Transcript - The Motley Fool
Organigram Reports Revenue Growth in Fiscal 2024, But Net Losses Continue - The Deep Dive
Organigram (NASDAQ:OGI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Organigram tops estimates, expands international reach ahead of major deal - Green Market Report
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars - Benzinga
OrganiGram Holdings 4Q Profit, Revenue Rise - MarketWatch
Organigram Acquires Motif Labs, Becomes Canada’s Largest Cannabis Company - Yahoo Finance
Organigram Increases Revenue and Adjusted EBITDA in Q4 - New Cannabis Ventures
ATB Capital Has Lowered Expectations for Organigram (TSE:OGI) Stock Price - MarketBeat
Organigram acquires Motif Labs in strategic move By Investing.com - Investing.com Nigeria
Organigram acquires Motif Labs in strategic move - Investing.com
Why BigBear.ai Stock Skyrocketed Today - AOL
Could Buying Archer Aviation Stock Today Set You Up for Life? - AOL
Organigram, VersaBank, Roots and more: Small-cap stocks that should be on your radar - The Globe and Mail
Organigram to Announce Q4 and Fiscal 2024 Results - TipRanks
GFG Resources Inc. - Baystreet.ca
Organigram Holdings Inc. - Baystreet.ca
Organigram Holdings Inc (OGI-T) QuotePress Release - The Globe and Mail
Organigram FY2024 EPS Boosted by Alliance Global Partners - MarketBeat
Atb Cap Markets Boosts Earnings Estimates for Organigram - MarketBeat
Alliance Global Partners Weighs in on Organigram Q4 Earnings - MarketBeat
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024 - Business Wire
Organigram leans into hemp with latest acquisition - Green Market Report
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive
Finanzdaten der Organigram Holdings Inc-Aktie (OGI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):